Q2 FY2026 · ended Sep 30, 2025 · Revenue $1.53M, -13.0% YoY · Filed Nov 13, 2025
Encision, Inc. (ECIA) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Sep 30, 2025, it reported revenue of $1.5 million and a net loss of $267,833. Free cash flow was -$163,321. As of Sep 30, 2025 it held $71,731 in cash and investments and $1.3 million in total debt.
Revenue
$1.53M
-13.0% vs year-ago quarter
Net income
$-267,833
-57.3% vs year-ago quarter
Operating cash flow
$-126,641
-268.5% vs year-ago quarter
Free cash flow
$-163,321
-449.3% vs year-ago quarter
EPS
$-0.02
-100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
16.88M
+42.1% vs year-ago quarter
Net cash
$-1.23M
Q2 FY2026
Operating margin
-5.1%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ECIA (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- CO
- Headquarters
- Boulder, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 930775
- Former names
- ELECTROSCOPE INC (until Aug 1, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Sep 30, 2025 |
Q1 FY2026 Jun 30, 2025 |
Q4 FY2025 Mar 31, 2025 |
Q3 FY2025 Dec 31, 2024 |
Q2 FY2025 Sep 30, 2024 |
|---|---|---|---|---|---|
| Revenue | $1.5M | $1.6M | $1.6M | $1.6M | $1.8M |
| Operating income | -$258,491 | -$19,780 | -$20,537 | -$20,867 | -$158,918 |
| Net income | -$267,833 | -$41,133 | -$47,308 | -$24,668 | -$170,262 |
| Diluted EPS | -$0.02 | $0.00 | -$0.00 | $0.00 | -$0.01 |
| Operating cash flow | -$126,641 | -$115,508 | -$201,802 | -$45,845 | $75,171 |
| Free cash flow | -$163,321 | -$122,043 | -$208,721 | -$64,620 | $46,756 |
| Total assets | $4.1M | $4.1M | $3.7M | $3.9M | $3.5M |
| Total liabilities | $2.2M | $2.5M | $2.0M | $2.2M | $1.8M |
| Stockholders' equity | $1.9M | $1.6M | $1.7M | $1.7M | $1.7M |
| Cash and investments | $71,731 | $47,918 | $257,433 | $347,919 | $230,014 |
| Total debt | $1.3M | $1.3M | $696,610 | $799,419 | $896,141 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2025 | Dec 8, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Shareholder vote results, Regulation FD disclosure
|
Aug 22, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 15, 2025 | Jun 30, 2025 |
All 745 Encision, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.